Thursday - March 12, 2026

Brenmiller Energy’s Edison Award Highlights What the Market Hasn’t Priced In-Yet ($BNRG)

Brenmiller Energy stock jumped about 15% on Wednesday following news of its Edison Award “Gold” Energy markets are noisy. Flashy startups, massive funding rounds, grand decarbonization promises—and a whole lot of “almosts.” But every now and then, the noise breaks … Continue reading

Hepatitis B Virus (HBV) Infection Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Hepatitis B Virus (HBV) Infection Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical … Continue reading

Solrikitug Emerges as a Promising Anti-TSLP Therapy for Severe Asthma, Poised to Address Critical Unmet Needs | DelveInsight

The major Severe Asthma companies iin the market such as AstraZeneca, Sanofi, Teva, GSK, Regeneron, Amgen, Ellodi, Bristol Myers Squibb, Revolo, EsoCap, and Pfizer, is expected to transform with the introduction of Solrikitug in the coming months.   Solrikitug (formerly … Continue reading

Oncocytoma Market Poised for Steady Growth by 2032, Driven by Improved Diagnostics | DelveInsight

The Oncocytoma market is experiencing notable growth, with the 7MM projected to achieve a decent CAGR, according to DelveInsight’s latest analysis. This growth reflects advancements in molecular diagnostics and minimally invasive surgical technologies that are reshaping treatment paradigms for this … Continue reading